Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Raffeld

Showing results (221-230 of 276) with videos related to

Pageof 28
Sort By:
Blood|December 24, 2024
Non-V600E BRAF mutations and treatment for hairy cell leukemiaEvgeny Arons, Chin-Hsien Tai, Joshi Suraj, et al.
The American Journal of Pathology|September 13, 2015
IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphomaShweta Jain, Jing Chen, Alina Nicolae, et al.
Blood|March 23, 2013
Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndromeAmy D Klion, Rojelio Mejia, Edward W Cowen, et al.
Blood|April 4, 2002
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacyWyndham H Wilson, Michael L Grossbard, Stefania Pittaluga, et al.
Blood Advances|May 30, 2017
The clinical spectrum of Erdheim-Chester disease: an observational cohort studyJuvianee I Estrada-Veras, Kevin J O'Brien, Louisa C Boyd, et al.
Autophagy|July 15, 2022
Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in <i>ATG9A</i>Guowu Hu, Pia J Hauk, Nannan Zhang, et al.
Blood|December 6, 2012
Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemiaThomas A Waldmann, Kevin C Conlon, Donn M Stewart, et al.
Blood|January 5, 2017
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemiaInhye E Ahn, Chingiz Underbayev, Adam Albitar, et al.
Journal of Medical Genetics|September 24, 2024
A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau diseaseCathy D Vocke, Christopher J Ricketts, Svetlana Pack, et al.
Blood Advances|October 4, 2021
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variantDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Pageof 28

Showing results (221-230 of 276) with videos related to

Sort By:
Pageof 28
Blood|December 24, 2024
Non-V600E BRAF mutations and treatment for hairy cell leukemiaEvgeny Arons, Chin-Hsien Tai, Joshi Suraj, et al.
The American Journal of Pathology|September 13, 2015
IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphomaShweta Jain, Jing Chen, Alina Nicolae, et al.
Blood|March 23, 2013
Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndromeAmy D Klion, Rojelio Mejia, Edward W Cowen, et al.
Blood|April 4, 2002
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacyWyndham H Wilson, Michael L Grossbard, Stefania Pittaluga, et al.
Blood Advances|May 30, 2017
The clinical spectrum of Erdheim-Chester disease: an observational cohort studyJuvianee I Estrada-Veras, Kevin J O'Brien, Louisa C Boyd, et al.
Autophagy|July 15, 2022
Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in <i>ATG9A</i>Guowu Hu, Pia J Hauk, Nannan Zhang, et al.
Blood|December 6, 2012
Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemiaThomas A Waldmann, Kevin C Conlon, Donn M Stewart, et al.
Blood|January 5, 2017
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemiaInhye E Ahn, Chingiz Underbayev, Adam Albitar, et al.
Journal of Medical Genetics|September 24, 2024
A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau diseaseCathy D Vocke, Christopher J Ricketts, Svetlana Pack, et al.
Blood Advances|October 4, 2021
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variantDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Pageof 28